Chapter 33 The history of movement disorders

Adams, 1949, The neurological changes in the more common types of severe liver disease, Trans Am Neurol Assoc, 74, 217 Adams, 1953, The neurological disorders associated with liver disease, Res Publ Assoc Res Nerv Ment Dis, 32, 198 Adams, 1964, Striato-nigral degeneration, J Neuropathol Exp Neurol, 23, 584 Albin, 1989, The functional anatomy of basal ganglia disorders, Trends Neurosci, 12, 366, 10.1016/0166-2236(89)90074-X Albin, 1989, Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity, Brain Res, 491, 185, 10.1016/0006-8993(89)90103-0 Albin, 1990, Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease, N Engl J Med, 322, 1293, 10.1056/NEJM199005033221807 Albin, 1992, Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease, Ann Neurol, 31, 425, 10.1002/ana.410310412 Alexander, 1986, Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Annu Rev Neurosci, 9, 357, 10.1146/annurev.ne.09.030186.002041 Altenmüller, 2005, 179 Alzheimer A, 1911, Über die anatomische Grundlage der Huntingtonischen Chorea und der choreatischen Bewegungen überhaupt, Z Gesamte Neurol Psychiatr, 3, 566 1998, ACMG/ASHG statement: laboratory guidelines for Huntington disease genetic testing, Am J Hum Genet, 62, 1243, 10.1086/301846 Anden, 1964, Demonstration and mapping out of nigro-neostriatal dopamine neurons, Life Sci, 3, 523, 10.1016/0024-3205(64)90161-4 Anden, 1965, Further evidence for the presence of nigro-striatal dopamine neurons in the rat, Am J Anat, 116, 329, 10.1002/aja.1001160117 Andermann, 1980, Startle disease or hyperekplexia: further delineation of the syndrome, Brain, 103, 985, 10.1093/brain/103.4.985 Andrew, 1993, The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease, Nat Genet, 4, 398, 10.1038/ng0893-398 Arima, 1998, NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy, Acta Neuropathol (Berl), 96, 439, 10.1007/s004010050917 Ayd, 1961, A survey of drug-induced extrapyramidal reactions, JAMA, 75, 1054, 10.1001/jama.1961.03040120016004 Aziz, 1991, Lesions of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate, Mov Disord, 6, 288, 10.1002/mds.870060404 Barbeau, 1958, The understanding of involuntary movements: an historical approach, J Nerv Ment Dis, 127, 469, 10.1097/00005053-195812000-00001 Barbeau, 1965, Dégénérescence plurisystématisée du nevraxe. Syndrome de Steele–Richardson–Olszewski, Union Med Can, 94, 715 Barbeau, 1970, Parental ascent in the juvenile form of Huntington's chorea, Lancet, 2, 927 Barbeau, 1962, Les catécholamines dans la maladie de Parkinson, 247 Barraquer-Bordas, 1988, Idiopathic torsion dystonia as described by Barraquer-Roviralta, Adv Neurol, 50, 665 Barraquer-Roviralta, 1897, Contribución al estudio de la atetosis, Gac Med Catalana, 20, 385 Beal, 1986, Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid, Nature, 32, 168, 10.1038/321168a0 Beard, 1869, Neurasthenia, or nervous exhaustion, Boston Medical and Surgical Journal, 80, 217, 10.1056/NEJM186904290801301 Beard, 1878, Dr. Beard's verbal communication, J Nerv Ment Dis, 5, 525 Beard, 1880, Experiments with the “jumpers” or “jumping Frenchmen” of Maine, J Nerv Ment Dis, 7, 487 Beard, 1880, Experiments with the “jumpers” of Maine, Popul Sci Monthly, 18, 170 Beard, 1871, 452 Bearn, 1957, Wilson's disease. An inborn error of metabolism with multiple manifestations, Am J Med, 22, 747, 10.1016/0002-9343(57)90125-0 Bearn, 1960, A genetical analysis of 30 families with Wilson's disease (hepatolenticular degeneration), Ann Hum Genet, 24, 33, 10.1111/j.1469-1809.1959.tb01713.x Bearn, 1952, Biochemical abnormalities in Wilson's disease, J Clin Invest, 31, 616 Bell, 1830, 221 Benabid, 1987, Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease, Appl Neurophysiol, 50, 344 Benabid, 1991, Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus, Lancet, 337, 403, 10.1016/0140-6736(91)91175-T Benabid, 1994, Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease, Stereotact Funct Neurosurg, 62, 76, 10.1159/000098600 Benazzouz, 1993, Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys, Eur J Neurosci, 5, 382, 10.1111/j.1460-9568.1993.tb00505.x Berciano, 1999, An early description of striatonigral degeneration, J Neurol, 246, 462, 10.1007/s004150050384 Bergman, 1990, Reversal of experimental parkinsonism by lesions of the subthalamic nucleus, Science, 249, 1436, 10.1126/science.2402638 Bergman, 1994, The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism, J Neurophysiol, 72, 507, 10.1152/jn.1994.72.2.507 Bertler, 1959, Occurrence and distribution of catechol amines in brain, Acta Physiol Scand, 47, 350 Birkmayer, 1961, Der L-3,4-Dioxyphenylalanin (=DOPA)-Effekt bei der Parkinson-Akinese, Wien Klin Wochenschr, 73, 787 Blackwood, 1889, Mechanical writing in the prevention and cure of writers' cramp and allied disorders, Medical Register (Philadelphia), 5, 365 Blocq, 1893, Sur un cas de tremblement parkinsonien hémiplégique symptomatique d'une tuneur du peduncle cerebral, Comptes Rendus Hebdomadaires des Séances et Mémoires de la Société de Biologie, 5, 105 Bouteille, 1810 Bramwell, 1916, Familial cirrhosis of the liver: four cases of acute fatal cirrhosis in the same family, the patients being respectively nine, ten, fourteen and fourteen years of age: suggested relationship to Wilson's progressive degeneration of the lenticular nucleus, Edinburgh Med J, 17, 90 Brandt, 1996, Trinucleotide repeat length and clinical progression in Huntington's disease, Neurology, 46, 527, 10.1212/WNL.46.2.527 Brewer, 1983, Oral zinc therapy for Wilson's disease, Ann Intern Med, 99, 314, 10.7326/0003-4819-99-3-314 Brewer, 1998, Treatment of Wilson's disease with zinc. XV. Long-term follow-up studies, J Lab Clin Med, 132, 264, 10.1016/S0022-2143(98)90039-7 Bright, 1831 Brin, 1987, Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm, Mov Disord, 2, 237, 10.1002/mds.870020402 Brissaud, 1895 Broadbent, 1869, On the pathology of chorea, Br Med J, 86, 345, 10.1136/bmj.1.433.345 Browning, 1908, Rev. Charles Oscar Waters, M.D, Neurographs, 1, 137 Browning, 1908, Irving Whitall Lyon, M.D, Neurographs, 1, 147 Brusa, 2004, Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism, Mov Disord, 19, 247, 10.1002/mds.10699 Bull, 1993, The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene, Nat Genet, 5, 327, 10.1038/ng1293-327 Burke, 1986, Torsion dystonia: a double-blind, prospective trial of high-dosage trihexphenidyl, Neurology, 36, 160, 10.1212/WNL.36.2.160 Burns, 1983, A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Proc Natl Acad Sci USA, 80, 4546, 10.1073/pnas.80.14.4546 Burr, 1895, Local spasms. Occupation spasms, 275 Butler, 1979, Biogenic amine metabolism in Tourette syndrome, Ann Neurol, 6, 37, 10.1002/ana.410060109 Buzzard, 1872, Two cases of impaired writing power treated successfully by electricity, Practitioner, 9, 65 Calne, 1971, Idiopathic parkinsonism treated with extracerebral decarboxylase inhibitor in combination with levodopa, Br Med J, 3, 729, 10.1136/bmj.3.5777.729 Calne, 1974, Bromocriptine in parkinsonism, Br Med J, 4, 442, 10.1136/bmj.4.5942.442 Campion, 1995, The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease, Genomics, 26, 254, 10.1016/0888-7543(95)80208-4 Canfield, 1884, A case of acute hemiplegic chorea; with autopsy and remarks, Boston Medical and Surgical Journal, 111, 220, 10.1056/NEJM188409041111002 Carlsson, 1959, The occurrence, distribution and physiological role of catecholamines in the nervous system, Pharmacol Rev, 11, 490 Carlsson, 2003, A half-century of neurotransmitter research: impact on neurology and psychiatry, 303 Carlsson, 1957, 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists, Nature, 180, 1200, 10.1038/1801200a0 Carpenter, 1950, Athetosis and the basal ganglia: Review of the literature and study of forty-two cases, Arch Neurol Psychiatry, 63, 875, 10.1001/archneurpsyc.1950.02310240034002 Carpenter, 1955, Ballism associated with partial destruction of the subthalamic nucleus of Luys, Neurology, 5, 479, 10.1212/WNL.5.7.479 Carpenter, 1951, Analysis of somatotopic relations of the corpus Luysi in man and monkey: relation between the site of dyskinesia and distribution of lesions within the subthalamic nucleus, J Comp Neurol, 95, 349, 10.1002/cne.900950205 Carpenter, 1950, Analysis of choreoid hyperkinesias in the rhesus monkey. Surgical and pharmacological analysis of hyperkinesias resulting from lesions in the subthalamic nucleus of Luys, J Comp Neurol, 92, 293, 10.1002/cne.900920303 Charcot, 1877, On paralysis agitans, 129 Charcot, 1881, On athetosis, Vol. 2, 390 Charcot, 1887, Tremblements et mouvements chroréiformes. Chorée rhythmée, 209 Charcot, 1887, Gilles de la Tourette syndrome: a child with convulsive tic and coprolalia: December 13, 1887, 56 Charcot, 1889, Tremors and choreiform movements – rhythmical chorea, Vol. 3, 183 Charcot, 1861, De la paralysie agitante, Gazette Hebdomadaire de Médecine et de Chirurgie, 8, 765 Chen, 1995, The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis, Genomics, 26, 425, 10.1016/0888-7543(95)80237-G Chien, 1967, Drug-induced extra-pyramidal symptoms and their relations to clinical efficacy, Am J Psychiatry, 123, 1490, 10.1176/ajp.123.12.1490 Ciechanover, 2005, Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting, 151 Coburn, 1931 Coburn, 1939, The prophylactic use of sulfonamide in streptococcal respiratory infections, with special reference to rheumatic fever, J Clin Invest, 18, 147, 10.1172/JCI101016 Cohen, 1979, Central biogenic amine metabolism in children with syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine, J Am Acad Child Psychiatry, 18, 320, 10.1016/S0002-7138(09)61046-3 Conn, 1960, Asterixis in non-hepatic disorders, Am J Med, 29, 647, 10.1016/0002-9343(60)90098-X Corbin, 1949, Trihexyphenyl: evaluation of a new agent in the treatment of Parkinson's disease, JAMA, 141, 373, 10.1001/jama.1949.02910060015004 Correns, 1900, Mendel's Regel über das Verhalten der Nachkommenschaft der Rassenbastarde, Berichte der Deutschen Botanischen Gesellschaft, 18, 158, 10.1111/j.1438-8677.1900.tb04893.x Corrodi, 1973, Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons, J Pharm Pharmacol, 25, 409, 10.1111/j.2042-7158.1973.tb10037.x Cotzias, 1967, Aromatic acids and modification of parkinsonism, N Engl J Med, 276, 374, 10.1056/NEJM196702162760703 Cotzias, 1969, Modification of parkinsonism – chronic treatment with L-dopa, N Engl J Med, 280, 337, 10.1056/NEJM196902132800701 Cotzias, 1970, Similarities between neurologic effects of DOPA and of apomorphine, N Engl J Med, 282, 31, 10.1056/NEJM197001012820107 Cotzias, 1976, Treatment of Parkinson disease with apomorphines: possible role of growth hormone, N Engl J Med, 294, 567, 10.1056/NEJM197603112941101 Coyle, 1976, Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea, Nature, 263, 244, 10.1038/263244a0 Creutzfeldt, 1920, Über eine eigenartige herdomige Erkrankung des Zentralnervensystems, Z Gesamte Neurol Psychiatr, 57, 1, 10.1007/BF02866081 Critchley, 1949, Observations on essential (heredofamilial) tremor, Brain, 72, 113, 10.1093/brain/72.2.113 Crossman, 1989, Neural mechanism in disorders of movement, Comp Biochem Physiol A, 93, 141, 10.1016/0300-9629(89)90201-6 Cumings, 1948, The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration, Brain, 71, 410, 10.1093/brain/71.4.410 Cumings, 1951, The effects of BAL in hepatolenticular degeneration, Brain, 74, 10, 10.1093/brain/74.1.10 Dale, 2004, Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity, Brain, 127, 21, 10.1093/brain/awh008 Dana, 1887, Hereditary tremor: a hitherto undescribed form of motor neurosis, Am J Med Sci, 94, 386, 10.1097/00000441-188710000-00005 Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 Davis, 1951, Benign essential (heredofamilial) tremor, Arch Intern Med, 87, 808, 10.1001/archinte.1951.03810060035004 Davis, 1979, Chronic parkinsonism secondary to intravenous injections of meperidine analogues, Psychiatry Res, 1, 249, 10.1016/0165-1781(79)90006-4 Dawbarn, 1985, Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's disease, Brain Res, 340, 251, 10.1016/0006-8993(85)90921-7 Dawson, 1934, Cellular inclusions in cerebral lesions of epidemic encephalitis (Second report), Arch Neurol Psychiatry, 31, 685, 10.1001/archneurpsyc.1934.02250040009001 de la Boë, 1663 De Vries, 1900, Sur la loi de disjonction des hybrides, C R Acad Sci, 130, 845 Degwitz, 1960, Über die Wirkungen des L-DOPA beim Menschen und deren Beeinflussung durch Reserpin, Chlorpromazin, Iproniazid und Vitamin B6, Wien Klin Wochenschr, 38, 120, 10.1007/BF02189076 Dejerine, 1900, 13, 330 Dejerine, 1900, Olivopontocerebellar atrophy, 219 Delay, 1952, Utilisation en thérapeutique psychiatrique d'une phénothiazine d'action centrale élective, Ann Med Psychol (Paris), 110, 112 DeLong, 1990, Primate models of movement disorders of basal ganglia origin, Trends Neurosci, 13, 281, 10.1016/0166-2236(90)90110-V Dening, 1990, Eponymous confusion over Bruno Fleischer, Lancet, 335, 291, 10.1016/0140-6736(90)90108-H Denny Brown, 1951, The effects of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease), N Engl J Med, 245, 917, 10.1056/NEJM195112132452401 Dewey, 1989, Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients, Arch Neurol, 46, 862, 10.1001/archneur.1989.00520440044020 Dickman, 2001, Von Economo encephalitis, Arch Neurol, 58, 1696, 10.1001/archneur.58.10.1696 DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 Dooling, 1975, The pathological anatomy of posthemiplegic athetosis, Brain, 98, 29, 10.1093/brain/98.1.29 Dorshay, 1949, Active therapy for parkinsonism, JAMA, 140, 1317 Dupont, 1973, Treatment of benign essential tremor with propranolol. A controlled clinical trial, Acta Neurol Scand, 49, 75, 10.1111/j.1600-0404.1973.tb01280.x Duyao, 1993, Trinucleotide repeat length instability and age of onset in Huntington's disease, Nat Genet, 4, 387, 10.1038/ng0893-387 Ehringer, 1960, Verteilung von Adrenalin und Dopamin (3-Hydroxytyramin) im Gehim des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems, Wien Klin Wochenschr, 38, 1236, 10.1007/BF01485901 Eldridge, 1970, The torsion dystonias: literature review and genetic and clinical studies, Neurology, 20, 1, 10.1212/WNL.20.11_Part_2.1 Elston, 1985, Effect of treatment with botulinum toxin on neurogenic blepharospasm, Br Med J (Clin Res Ed), 290, 1857, 10.1136/bmj.290.6485.1857 Ernst, 1965, Relation between action of dopamine and apomorphine and the O-methylated derivatives upon the CNS, Psychopharmacology (Berl), 7, 391, 10.1007/BF00402361 Eschner, 1897, A graphic study of tremor, J Exp Med, 2, 301, 10.1084/jem.2.3.301 Fahn, 1983, High-dosage anticholinergic therapy in dystonia, Adv Neurol, 37, 177 Fahn, 1988, Concept and classification of dystonia, Adv Neurol, 50, 1, 10.1212/WNL.50.5_Suppl_5.S1 Farrer, 1992, Inverse relationship between age at onset of Huntington disease and paternal age suggests involvement of genetic imprinting, Am J Hum Genet, 50, 528 Faurbye, 1964, Neurological symptoms in pharmacotherapy of psychosis, Acta Psychiatr Scand, 40, 10, 10.1111/j.1600-0447.1964.tb05731.x Fehling, 1966, Treatment of Parkinson's syndrome with L-DOPA: a double blind study, Acta Neurol Scand, 42, 367, 10.1111/j.1600-0404.1966.tb01188.x Ferrante, 1985, Selective sparing of a class of striatal neurons in Huntington's disease, Science, 230, 561, 10.1126/science.2931802 Ferrante, 1987, Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease, J Neuropathol Exp Neurol, 46, 12, 10.1097/00005072-198701000-00002 Ferrier, 1876 Findley, 1985, Primidone in essential tremor of the hands and head: a double-blind controlled clinical study, J Neurol Neurosurg Psychiatry, 481, 911, 10.1136/jnnp.48.9.911 Flatau, 1911, Progressiver Torsionspasmus bei Kindern, Z Gesamte Neurol Psychiatr, 7, 586, 10.1007/BF02865155 Fleischer, 1903, Zwei weitere Fälle von grünlicher Verfärbung der Kornea, Klin Monatsbl Augenheilkd, 41, 335 Foley, 2000, The L-DOPA story revisited. Further surprises to be expected? The contribution of Isamu Sano to the investigation of Parkinson's disease, J Neural Transm Suppl, 60, 1 Foley, 2003, Beans, roots and leaves: a brief history of the pharmacological therapy of parkinsonism, Wurzbg Medizinhist Mitt, 22, 215 Forel, 1877, Untersuchungen über die Haubenregion und ihre oberen Verknupfungen im Gehirne des Menschen und einiger Saügethiere, mit Beiträgen zu den Methoden des Gehirnuntersuchungen, Arch Psychiatr Nervenkr, 7, 182, 10.1007/BF02041873 Forno, 1986, Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys, Ann Neurol, 20, 449, 10.1002/ana.410200403 Freyhan, 1957, Psychomotility and parkinsonism in treatment with neuroleptic drugs, Arch Neurol Psychiatry, 78, 465, 10.1001/archneurpsyc.1957.02330410029003 Friedreich, 1863, Über degenerative Atrophie der spinalen Hinterstränge, Virchows Arch Pathol Anat Physiol Klin Med 26: 391–419, 433–459;, 27, 1, 10.1007/BF01938516 Friedreich, 1881, Neuropathologische Beobachtung beim Paramyoklonus Multiplex, Virchows Arch Pathol Anat Physiol Klin Med, 86, 421, 10.1007/BF01915725 Fritsch, 1870, On the electrical excitability of the cerebrum, 73 Frucht, 2000, The clinical spectrum of posthypoxic myoclonus, Mov Disord, 15, 2, 10.1002/mds.870150702 Frydman, 1985, Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus, Proc Natl Acad Sci USA, 82, 1819, 10.1073/pnas.82.6.1819 Furtado, 1996, Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease, Ann Neurol, 39, 132, 10.1002/ana.410390120 Galilei, 1610, Letter dated January 7, 1610, 147 Giasson, 2000, Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions, Science, 290, 985, 10.1126/science.290.5493.985 Gibb, 1989, Corticobasal degeneration, Brain, 112, 1171, 10.1093/brain/112.5.1171 Gildenberg, 1998, The history of surgery for movement disorders, Neurosurg Clin N Am, 9, 283, 10.1016/S1042-3680(18)30264-X Gilles de la Tourette, 1881, Les “sauteurs” du Maine (États-Unis): Par G, Beard. Arch Neurol (Paris), 2, 146 Gilles de la Tourette, 1884, Jumping, Latah, Myriachit, Arch Neurol (Paris), 8, 68 Gilles de la Tourette, 1885, Étude sur une affection nerveuse caracterisée par l'incoordination motrice accompagnée d'écholalie et de coprolalie, Arch Neurol (Paris), 9, 19 Gilliam, 1987, Localization of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere, Cell, 50, 565, 10.1016/0092-8674(87)90029-8 Gilman, 1997, G proteins and regulation of adenylyl cyclase, 182 Glazebrook, 1945, Wilson's disease, Edinburgh Med J, 52, 83 Goetz, 1986, Charcot on Parkinson's disease, Mov Disord, 1, 27, 10.1002/mds.870010104 Goetz, 1982, Gilles de la Tourette on Tourette syndrome, Adv Neurol, 35, 1 Goetz, 1995, 113 Goetz, 2001, The basal ganglia: part 1 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 152, 10.1002/1531-8257(200101)16:1<152::AID-MDS1027>3.0.CO;2-I Goetz, 2001, The history of Parkinson's disease: part 2 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 156, 10.1002/1531-8257(200101)16:1<156::AID-MDS1028>3.0.CO;2-B Goetz, 2001, Seminal figures in the history of movement disorders: Sydenham, Parkinson, and Charcot: part 6 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 537, 10.1002/mds.1113 Goetz, 2001, Parkinson-plus syndromes: part 7 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 541, 10.1002/mds.1114 Goetz, 2001, History of chorea: part 3 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 331, 10.1002/mds.1066 Goetz, 2001, Seminal figures in the history of movement disorders: Gilles de la Tourette, Oppenheim, the Vogts, von Economo, Wilson, and Marsden: part 12 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 940, 10.1002/mds.1189 Goetz, 2001, History of dystonia: part 4 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 339, 10.1002/mds.1067 Goetz, 2001, History of myoclonus: part 8 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 545, 10.1002/mds.1115 Goetz, 2001, History of tic disorders and Gilles de la Tourette syndrome: part 5 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 346, 10.1002/mds.1068 Goff, 1991, The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial, J Clin Psychopharmacol, 11, 106 Golbe, 1990, A large kindred with autosomal dominant Parkinson's disease, Ann Neurol, 27, 276, 10.1002/ana.410270309 Goldman, 1992, The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor, J Neurosurg, 76, 924, 10.3171/jns.1992.76.6.0924 Goldstein, 1966, The effects of ventromedial segmental lesions on the biosynthesis of catecholamines in the striatum, Life Sci, 5, 2171, 10.1016/0024-3205(66)90078-6 Gowers, 1876, On “athetosis” and post-hemiplegic disorders of movement, Med Chir Trans, 271, 10.1177/095952877605900119 Gowers, 1888 Gowers, 1906, On tetanoid chorea and its association with cirrhosis of the liver, Reviews of Neurology and Psychiatry, 4, 249 Graham, 1969, Orthostatic hypotension, and nicotine sensitivity in a case of multiple system atrophy, J Neurol Neurosurg Psychiatry, 32, 28, 10.1136/jnnp.32.1.28 Greenfield, 1953, The brain-stem lesions in parkinsonism, J Neurol Neurosurg Psychiatry, 16, 213, 10.1136/jnnp.16.4.213 Greenfield, 1922, The pathology of Sydenham's chorea, Lancet, 2, 603, 10.1016/S0140-6736(01)01044-3 Groth, 1973, Hepatic transplantation in Wilson disease, Birth Defects Orig Artic Ser, 9, 106 Grundmann, 2005, Primary torsion dystonia, Arch Neurol, 62, 682, 10.1001/archneur.62.4.682 Guridi, 2001, The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma, Brain, 124, 5, 10.1093/brain/124.1.5 Gusella, 1983, A polymorphic DNA marker genetically linked to Huntington's disease, Nature, 306, 234, 10.1038/306234a0 Gusella, 1985, Deletion of Huntington's disease linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome, Nature, 318, 75, 10.1038/318075a0 Hall, 1921, La Dégénérescence Hepatolenticulare Hall, 1956, Neurotoxic reactions resulting from chlorpromazine administration, JAMA, 161, 214, 10.1001/jama.1956.02970030032008 Hallett, 1986, Early history of myoclonus, Adv Neurol, 43, 7 Hamada, 1992, Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding, J Neurophysiol, 68, 1859, 10.1152/jn.1992.68.5.1859 Hamani, 2003, The subthalamic nucleus in the context of movement disorders, Brain, 127, 4, 10.1093/brain/awh029 Haméleers, 2006, History of the corpus Luysii: 1865–1995, Arch Neurol, 63, 1340, 10.1001/archneur.63.9.1340 Hammond, 1890, Pathological findings in the original case of athetosis, J Nerv Ment Dis, 17, 555 Hammond, 1871, Athetosis, 654 Hammond, 1884, Miryachit: a newly described disease of the nervous system, and its analogues, New York Medical Journal, 39, 191 Hammond, 1893, Athetosis, 315 Hamon, 1952, Remarques sur l'action du 4560 RP sur l'agitation maniaque, Ann Med Psychol (Paris), 110, 331 Haškovec, 1901, L'Akathisie, Rev Neurol, 9, 1107 Hassler, 1938, Zur Pathologie der Paralysis agitans und des post-encephalitischen Parkinsonismus, Journal für Psychologie und Neurologie, 18, 387 Hassler, 1954, Indikationen und Lokalisationsmethode der gezielten Hirnoperationen, Nervenartz, 25, 441 Haurowitz, 1930, Über eine Anomalie des Kupferstoffwechsels, Hoppe-Seylers Z Physiol Chem, 190, 72, 10.1515/bchm2.1930.190.1-2.72 Hayashi, 2000, An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene, Mov Disord, 15, 884, 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8 Heikkila, 1984, Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors, Nature, 311, 467, 10.1038/311467a0 Hershko, 2005, The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle, 187 Herz, 1944, Dystonia I. Historical review, analysis of dystonic symptoms and psychologic mechanisms involved, Arch Neurol Psychiatry, 51, 305, 10.1001/archneurpsyc.1944.02290280003001 Herz, 1944, Dystonia II. Clinical classification, Arch Neurol Psychiatry, 51, 319, 10.1001/archneurpsyc.1944.02290280017002 Herz, 1944, Dystonia III. Pathology and conclusions, Arch Neurol Psychiatry, 52, 20, 10.1001/archneurpsyc.1944.02290310026002 Holdorff, 2002, Friedrich Heinrich Lewy (1885–1950) and his work, J Hist Neurosci, 11, 19, 10.1076/jhin.11.1.19.9106 Holmberg, 1947, Investigations in serum copper. I. Nature of serum copper and its relation to the iron-binding protein in human serum, Acta Chem Scand, 1, 944, 10.3891/acta.chem.scand.01-0944 Holmberg, 1948, Investigations in serum copper. II. Isolation of the copper containing protein, and a description of some of its properties, Acta Chem Scand, 2, 550, 10.3891/acta.chem.scand.02-0550 Hoogenraad, 1979, Oral zinc sulfate as long-term treatment in Wilson's disease (hepatolenticular degeneration), Eur Neurol, 18, 205, 10.1159/000115077 Hoogenraad, 1987, Management of Wilson's disease with zinc sulfate: experience in a series of 27 patients, J Neurol Sci, 77, 137, 10.1016/0022-510X(87)90116-X Hoogeveen, 1993, Characterization and localization of the Huntington disease gene product, Hum Molec Genet, 2, 2069, 10.1093/hmg/2.12.2069 Hornykiewicz, 2001, How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago, Wien Klin Wochenschr, 113, 855 Howard, 1992, From the jumping Frenchmen of Maine to post-traumatic stress disorder: the startle response in neuropsychiatry, Psychol Med, 22, 695, 10.1017/S0033291700038137 Huntington, 1872, On chorea, Medical and Surgical Reporter, 26, 317 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E Husby, 1976, Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever, J Exp Med, 144, 1094, 10.1084/jem.144.4.1094 Ishikawa, 1995, A family with hereditary juvenile dystonia-parkinsonism, Mov Disord, 10, 482, 10.1002/mds.870100413 Itard, 1825, Mémoire sur quelques fonctions involontaires des appareils de la locomotion, de la préhension et de la voix, Archives Générales de Medecine, 8, 385 Jackson, 1868, Observations on the physiology and pathology of hemi-chorea, Vol. 2, 238 Jackson, 1876, On epilepsies and on the after-effects of epileptic discharges (Todd and Robertson's hypothesis), 135 Jager, 1955, Hereditary tremor, Arch Intern Med, 95, 788, 10.1001/archinte.1955.00250120024003 Jakes, 1994, Identification of two distinct synucleins from human brain, FEBS Lett, 345, 27, 10.1016/0014-5793(94)00395-5 Jakob, 1921, Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswerten anatomischen Befunden (spastische Pseudosklerose, Encephalomyelopathie mit disseminierten Degenerationsherden), Z Gesamte Neurol Psychiatr, 64, 147, 10.1007/BF02870932 Jankovic, 1995, Outcomes after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor, Neurosurgery, 37, 680, 10.1227/00006123-199510000-00011 Johnson, 1990, Twin studies and the genetics of Parkinson's disease – a reappraisal, Mov Disord, 5, 187, 10.1002/mds.870050302 Jummani, 2001, Sydenham chorea, Arch Neurol, 58, 311, 10.1001/archneur.58.2.311 Kann, 2002, Role of parkin mutations in 111 community-based patients with early-onset parkinsonism, Ann Neurol, 51, 621, 10.1002/ana.10179 Kayser, 1902, Über einen Fall von angeborener grünlicher Verfärbung der Cornea, Klin Monstbl Augenheilkd, 40, 22 Kebabian, 1979, Multiple receptor mechanism for dopamine, Nature, 227, 93, 10.1038/277093a0 Keppel Hesselink, 1996, Evolution of concepts and definitions of Parkinson's disease since 1817, J Hist Neurosci, 5, 200, 10.1080/09647049609525668 Kitada, 1998, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 10.1038/33416 Klawans, 1976, Treatment and prognosis of hemiballismus, N Engl J Med, 295, 1348, 10.1056/NEJM197612092952404 Klawans, 1978, Gilles de la Tourette syndrome after long-term chlorpromazine therapy, Neurology, 28, 1064, 10.1212/WNL.28.10.1064 Klempel, 1974, Gilles de la Tourette's symptoms induced by L-dopa, S Afr Med J, 48, 1379 Koehler, 1997, Tremor in Latin texts of Dutch physicians: 16th–18th centuries, Mov Disord, 12, 798, 10.1002/mds.870120531 Kopp, 1836 Krack, 1999, Relics of dancing mania: the dancing procession of Echternach, Neurology, 53, 2169, 10.1212/WNL.53.9.2169 Krack, 2003, Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease, N Engl J Med, 349, 1925, 10.1056/NEJMoa035275 Kristensen, 1985, Progressive supranuclear palsy – 20 years later, Acta Neurol Scand, 71, 177, 10.1111/j.1600-0404.1985.tb03186.x Kruisdijk, 2007, Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up, J Neurol Neurosurg Psychiatry, 78, 264, 10.1136/jnnp.2005.083170 Kruse, 1960, Persistent muscular restlessness after phenothiazine treatment: report of three cases, Am J Psychiatry, 117, 152, 10.1176/ajp.117.2.152 Kunkle, 1965, The “jumpers” of Maine: past history and present status, J Maine Med Assoc, 56, 191 Kunkle, 1967, The “jumpers” of Maine: a reappraisal, Arch Intern Med, 119, 355, 10.1001/archinte.1967.00290220105005 Kurczynski, 1983, Hyperekplexia, Arch Neurol, 40, 246, 10.1001/archneur.1983.04050040076015 Kushner, 1999, A perplexing document in the early history of Gilles de la Tourette syndrome: Melotti's rendition of a “Lecture by Charcot” (including a complete translation from the Italian with commentary), J Hist Neurosci, 8, 5, 10.1076/jhin.8.1.5.1779 Lahti, 1995, D2-family receptor distribution in human postmortem tissue: an autoradiographic study, Neuroreport, 6, 2502, 10.1097/00001756-199512150-00015 Laitinen, 1992, Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease, J Neurosurg, 76, 53, 10.3171/jns.1992.76.1.0053 Laitinen, 1992, Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms, Stereotact Funct Neurosurg, 58, 14, 10.1159/000098965 Lajonchere, 1996, Gilles de la Tourette and the discovery of Tourette syndrome: includes a translation of his 1884 article, Arch Neurol, 53, 567, 10.1001/archneur.1996.00550060111024 Lance, 1963, The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy, Brain, 86, 111, 10.1093/brain/86.1.111 Lance, 2001, Negative myoclonus in posthypoxic patients: historical note, Mov Disord, 16, 162, 10.1002/1531-8257(200101)16:1<162::AID-MDS1029>3.0.CO;2-9 Lang, 1982, Anticholinergics in adult-onset focal dystonia, Can J Neurol Sci, 9, 313, 10.1017/S0317167100044139 Langston, 1995 Langston, 1983, Chronic parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219, 979, 10.1126/science.6823561 Langston, 1984, Pargyline prevents MPTP-induced parkinsonism in primates, Science, 225, 1480, 10.1126/science.6332378 Lanska, 2000, 19th-century American contributions to the recording of tremors, Mov Disord, 15, 720, 10.1002/1531-8257(200007)15:4<720::AID-MDS1019>3.0.CO;2-1 Lanska, 2000, George Huntington (1850–1916) and hereditary chorea, J Hist Neurosci, 9, 76, 10.1076/0964-704X(200004)9:1;1-2;FT076 Lanska, 2001, Characteristics and lasting contributions of 19th-century American neurologists, J Hist Neurosci, 10, 202, 10.1076/jhin.10.2.202.7252 Lanska, 2002, Classic articles by 19th-century American neurologists: a critical review, J Hist Neurosci, 11, 156, 10.1076/jhin.11.2.156.15196 Lanska, 2002, Limb immobilization for the treatment of focal occupational dystonia [Letter], Neurology, 58, 991, 10.1212/WNL.58.6.991 Lanska, 2002, 19th-century instruments for writer's cramp [Abstract], Neurology, 58, A341 Lanska, 2001, Development of instruments for abnormal movements: dynamometers, the dynamograph, and tremor recorders: part 9 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 736, 10.1002/mds.1155 Lanska, 2001, Seminal figures in the history of movement disorders: Huntington, Osler, and Hammond: part 11 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000, Mov Disord, 16, 749, 10.1002/mds.1157 Lantos, 1998, The definition of multiple system atrophy: a review of recent developments, J Neuropathol Exp Neurol, 57, 1099, 10.1097/00005072-199812000-00001 Larsson, 1960, Essential tremor: a clinical and genetic population study, Acta Psychiatr Scand, 26, 1 Leavitt, 1964, Studies in asterixis. Part I, Arch Neurol, 10, 360, 10.1001/archneur.1964.00460160030002 Leeflang, 1999, Analysis of germline mutation spectra at the Huntington's disease locus supports a mitotic mutation mechanism, Hum Mol Genet, 8, 173, 10.1093/hmg/8.2.173 Lehmann, 1954, Chlorpromazine: new inhibiting agent for psychomotor excitement and manic states, AMA Arch Neurol Psychiatry, 71, 227, 10.1001/archneurpsyc.1954.02320380093011 Lewis, 1885, The neural disorders of writers and artisans, 504 Lewy, 1913, Zur pathologischen Anatomie der Paralysis agitans, Dtsch Z Nervenheilkd, 50, 50 Limousin, 1995, Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation, Lancet, 345, 91, 10.1016/S0140-6736(95)90062-4 Limousin, 1998, Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease, N Engl J Med, 339, 1105, 10.1056/NEJM199810153391603 Limousin, 1999, Multicentre European study of thalamic stimulation in parkinsonian and essential tremor, J Neurol Neurosurg Psychiatry, 66, 289, 10.1136/jnnp.66.3.289 Lindemulder, 1933, Familial myoclonia occurring in three successive generations, J Nerv Ment Dis, 77, 489, 10.1097/00005053-193305000-00003 Lloyd, 1975, The neurochemistry of Parkinson's disease: effect of L-dopa therapy, J Pharmacol Exp Ther, 195, 453 Louis, 1997, The shaking palsy, the first forty-five years: a journey through the British literature, Mov Disord, 12, 1068, 10.1002/mds.870120638 Louis, 2001, Etiology of essential tremor: should we be searching for environmental causes, Mov Disord, 16, 822, 10.1002/mds.1183 Lucking, 2000, Association between early-onset Parkinson's disease and mutations in the parkin gene, N Engl J Med, 342, 1560, 10.1056/NEJM200005253422103 Lundborg, 1903 Luys, 1865 Lyon, 1863, Chronic hereditary chorea, American Medical Times, 7, 289 Ma, 2006, Familial essential tremor with apparent autosomal dominant inheritance: should we also consider other inheritance modes, Mov Disord, 21, 1368, 10.1002/mds.20950 McCall, 2001, Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases, J Neuropathol Exp Neurol, 60, 696, 10.1093/jnen/60.7.696 McGeer, 1976, Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic acid and kainic acids, Nature, 263, 517, 10.1038/263517a0 McGeer, 1964, Administration of dihydroxyphenylalanine to parkinsonian patients, Can Med Assoc J, 90, 463 Markey, 1984, Intraneuronal generation of a pyrimidium ion metabolite may cause drug-induced parkinsonism, Nature, 311, 464, 10.1038/311464a0 Marsden, 1985, The anatomical basis of symptomatic hemidystonia, Brain, 108, 463, 10.1093/brain/108.2.463 Martin, 1927, Hemichorea resulting from a local lesion of the brain: the syndrome of the body of Luys, Brain, 50, 637, 10.1093/brain/50.3-4.637 Martin, 1957, Hemichorea (hemiballismus) without lesions in the corpus Luysii, Brain, 80, 1, 10.1093/brain/80.1.1 Matsumine, 1997, Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27, Am J Hum Genet, 60, 588 Mauriello, 1985, Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin, Neurology, 35, 1499, 10.1212/WNL.35.10.1499 Meige, 1907, 27 Mendel, 1865, Versuche über Pflanzenhybriden, Verhandlungen des Naturfarschenden Vereines in Brünn, 4, 3 Merritt, 1969, Juvenile Huntington's chorea, 645 Meyers, 1940, Surgical procedure for postencephalitic tremor, with notes on the physiology of premotor fibers, Arch Neurol Psychiatry, 44, 455 Mink, 2003, The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns, Arch Neurol, 60, 1365, 10.1001/archneur.60.10.1365 Mitchell, 1980, Gilles de la Tourette's disease associated with pemoline, Am J Psychiatry, 137, 1617 Mitchell, 1985, Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey include the ventral tegmental area and the locus coeruleus, Neurosci Lett, 61, 195, 10.1016/0304-3940(85)90424-0 Mitchell, 1903, Report of a case of familial tremor of the head, J Nerv Ment Dis, 30, 158, 10.1097/00005053-190303000-00003 Mitchell, 1874, Post-paralytic chorea, Am J Med Sci, 68, 342, 10.1097/00000441-187410000-00002 Molina-Negro, 1975, Semiology of tremors, Can J Neurol Sci, 2, 23, 10.1017/S0317167100019946 Montagu, 1957, Catechol compounds in rat tissues and in brains of different animals, Nature, 180, 245, 10.1038/180244a0 Myers, 1982, Factors related to onset age of Huntington disease, Am J Hum Genet, 34, 481 Narbona, 1984, Hemidystonia secondary to localized basal ganglia tumour, J Neurol Neurosurg Psychiatry, 47, 704, 10.1136/jnnp.47.7.704 Nausieda, 1980, Sydenham chorea: an update, Neurology, 30, 331, 10.1212/WNL.30.3.331 Nutt, 1984, Cranial dystonia: double-blind crossover study of anticholinergics, Neurology, 34, 215, 10.1212/WNL.34.2.215 Obeso, 2000, Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model, Ann Neurol, 47, S22 O'Brien, 1981, Benign familial tremor treated with primidone, Br Med J, 282, 178, 10.1136/bmj.282.6259.178 Olney, 1978, Glutamic neurotoxicity and Huntington's chorea, Nature, 271, 557, 10.1038/271557a0 Olszewski, 1964, Pathological report on six cases of heterogeneous system degeneration, J Neuropathol Exp Neurol, 23, 187 Oppenheim, 1911, Über eine eigenartige Krampfkrankheit des kindlichen und jegendlichen Alters (Dysbasia lordotica progressiva, Dystonia musculorum deformans), Neurologisches Zentralblatt, 30, 1090 Ørbeck, 1959, An early description of Huntington's chorea, Med Hist, 3, 165, 10.1017/S0025727300024492 Osler, 1887, On the general etiology and symptoms of chorea: based on the records of 410 cases at the Infirmary for Nervous Diseases, Philadelphia, Medical News, 51, 437 Osler, 1894 Osler, 1908, Historical notes on hereditary chorea, Neurographs, 1, 113 Ozelius, 1989, Human gene for torsion dystonia located on chromosome 9q32-q34, Neuron, 2, 1427, 10.1016/0896-6273(89)90188-8 Ozelius, 1997, Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium, Genome Res, 7, 483, 10.1101/gr.7.5.483 Ozelius, 1997, The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein, Nat Genet, 17, 40, 10.1038/ng0997-40 Pahwa, 1999, Bilateral thalamic stimulation for the treatment of essential tremor, Neurology, 53, 1447, 10.1212/WNL.53.7.1447 Papp, 1992, Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy, J Neurol Sci, 107, 172, 10.1016/0022-510X(92)90286-T Papp, 1989, Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy–Drager syndrome), J Neurol Sci, 94, 79, 10.1016/0022-510X(89)90219-0 Parent, 2002, Jules Bernard Luys and the subthalamic nucleus, Mov Disord, 17, 181, 10.1002/mds.1251 Parkinson, 1817 Penny, 1997, CAG repeat number governs the development rate of pathology in Huntington's disease, Ann Neurol, 41, 689, 10.1002/ana.410410521 Perutz, 1994, Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases, Proc Natl Acad Sci USA, 91, 5355, 10.1073/pnas.91.12.5355 Petrukhin, 1993, Mapping, cloning and genetic characterization of the region containing the Wilson disease gene, Nat Genet, 5, 338, 10.1038/ng1293-338 Pettigrew, 1985, Hemidystonia: a report of 22 patients and a review of the literature, J Neurol Neurosurg Psychiatry, 48, 650, 10.1136/jnnp.48.7.650 Piccolomini, 1630 Poirer, 1965, Influence of the substantia nigra on the catecholamine content of the striatum, Brain, 88, 181, 10.1093/brain/88.1.181 Polymeropoulos, 1996, Mapping of a gene for Parkinson's disease to chromosome 4q21-q23, Science, 274, 1197, 10.1126/science.274.5290.1197 Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Poore, 1878, An analysis of 75 cases of writer's cramp and impaired writing power, Med Chir Trans, 61, 111, 10.1177/095952877806100111 Posey, 1904, Paralysis of upward movement of the eyes, Ann Ophthalmol, 13, 523 Poynton, 1913 Pramstaller, 2005, Lewy body Parkinson's disease in a large pedigree with 77 parkin mutation carriers, Ann Neurol, 58, 411, 10.1002/ana.20587 Putnam, 1879, A new adjuvant in the treatment of writer's palsy, Boston Medical and Surgical Journal, 101, 320, 10.1056/NEJM187908281010913 Rabinovitch, 1965, An exaggerated startle reflex resembling a kicking horse, Can Med Assoc J, 93, 130 Rammelkamp, 1952, Studies on the epidemiology of rheumatic fever in the armed services, 72 Ranen, 1995, Anticipation and instability of IT-15(CAG)n repeats in parent-offspring pairs with Huntington's disease, Am J Hum Genet, 57, 593 Rebeiz, 1967, Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life, Trans Am Neurol Assoc, 92, 23 Rebeiz, 1968, Corticodentatonigral degeneration with neuronal achromasia, Arch Neurol, 18, 20, 10.1001/archneur.1968.00470310034003 Reid, 2001, Experimenting on the past: the enigma of Von Economo's encephalitis lethargica, J Neuropathol Exp Neurol, 60, 663, 10.1093/jnen/60.7.663 Reik, 1988, Genomic imprinting: a possible mechanism for the parental origin effect in Huntington's chorea, J Med Genet, 25, 805, 10.1136/jmg.25.12.805 Reiner, 1988, Differential loss of striatal projection neurons in Huntington disease, Proc Natl Acad Sci USA, 85, 5733, 10.1073/pnas.85.15.5733 Richardson, 1963, Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia: a clinical report on eight cases of “heterogeneous system degeneration, Trans Am Neurol Assoc, 88, 25 Ridley, 1988, Anticipation in Huntington's disease is inherited through the male line but may originate in the female, J Med Genet, 25, 589, 10.1136/jmg.25.9.589 Ridley, 1991, Patterns of inheritance of the symptoms of Huntington's disease suggestive of an effect of genomic imprinting, J Med Genet, 28, 224, 10.1136/jmg.28.4.224 Riley, 1990, Cortical-basal ganglionic degeneration, Neurology, 40, 1203, 10.1212/WNL.40.8.1203 Ristic, 2002, Long-term prognosis of vascular hemiballismus, Stroke, 33, 2109, 10.1161/01.STR.0000022810.76115.C0 Robins, 1885, The treatment of writers' cramp, Proc Phil Co Med Soc, 7, 271 Robins, 1885, Writers' cramp” and its treatment, with the notes of several cases, Am J Med Sci, 89, 452, 10.1097/00000441-188504000-00012 Rodbell, 1997, Signal transduction: evolution of an idea, 220 Roger, 1866, Recherches cliniques sur la chorea, sur le rhumatisme et sur les maladies du Coeur chez les enfants, Archives Générales de Médecine, 2, 641 Rose, 2005, Ubiquitin at fox chase, 218 Rothfus, 1988, Improvement of cerebral CT abnormalities following liver transplantation in a patient with Wilson disease, J Comput Assist Tomogr, 12, 138, 10.1097/00004728-198801000-00027 Rubinsztein, 1996, Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats, Am J Hum Genet, 59, 16 Rumpel, 1913, Über das Wesen und die Bedeutung der Leberveränderungen und der Pigmentierungen bei den damit verbunderen Fällen von Pseudosklerose, zugleich ein Beitrag zur Lehre der Pseudosklerose (Westphal-Strumpell), Dtsch Z Nervenheilkd, 49, 54, 10.1007/BF01760543 Saint-Hilaire, 1986, Jumping Frenchmen of Maine, Neurology, 36, 1269, 10.1212/WNL.36.9.1269 Sano, 1959, Distribution of catechol compounds in human brain, Biochim Biophys Acta, 32, 586, 10.1016/0006-3002(59)90652-3 Scheinberg, 1952, Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease), Science, 116, 484, 10.1126/science.116.3018.484 Scheinberg, 1960, Long-term management of hepatolenticular degeneration (Wilson's disease), Am J Med, 29, 316, 10.1016/0002-9343(60)90028-0 Scherer, 1933, Beiträge zur pathologischen Anatomie des Kleinhirns. III. Mitteilung: Genuine Kleinhirnatrophien, Z Gesamte Neurol Psychiatr, 145, 335, 10.1007/BF02865875 Scherer, 1933, Extrapyramidale Störungen bei der olivopontocerebellaren Atrophie. Ein Beitrag zum Problem des lokalen vorzeitigen Alterns, Z Gesamte Neurol Psychiatr, 145, 406, 10.1007/BF02865876 Schiller, 1967, The vicissitudes of the basal ganglia (further landmarks in cerebral nomenclature), Bull Hist Med, 41, 515 Schiller, 1986, Parkinsonian rigidity: the first hundred-and-one years 1817–1918, Hist Philos Life Sci, 8, 221 Schiller, 2000, Fritz Lewy and his bodies, J Hist Neurosci, 9, 148, 10.1076/0964-704X(200008)9:2;1-Y;FT148 Schonecker, 1957, Ein eigentumliches Syndrom im oralen Bereich bei Megaphen Applikation, Nervenarzt, 28, 35 Schouwink, 1961 Schuurman, 2000, A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor, N Engl J Med, 342, 461, 10.1056/NEJM200002173420703 Schwab, 1951, Apomorphine in Parkinson's disease, Trans Am Neurol Assoc, 76, 273 Schwalbe, 1908 Scott, 1973, Pharmacologic weakening of extraocular muscles, Invest Ophthalmol Vis Sci, 12, 924 Sée, 1850, De la choreé, Mémoires de l'Académie Royale de Médecine (Paris), 15, 374 Seignot, 1961, A case of the syndrome of tics of Gilles de la Tourette controlled by R 1625, Ann Med Psychol, 28, 92 Shahani, 1976, Physiological and pharmacological aids in the differential diagnosis of tremor, J Neurol Neurosurg Psychiatry, 39, 772, 10.1136/jnnp.39.8.772 Shahzadi, 1995, Thalamotomy for essential and cerebellar tremor, Stereotact Funct Neurosurg, 565, 11, 10.1159/000098890 Shapiro, 1973, Treatment of Tourette's syndrome: with haloperidol, review of 34 cases, Arch Gen Psychiatry, 28, 92, 10.1001/archpsyc.1973.01750310070010 Sharp, 1994, Pseudochoreoathetosis: movements associated with loss of proprioception, Arch Neurol, 41, 1103, 10.1001/archneur.1994.00540230041010 Sheehy, 1982, Writer's cramp – a focal dystonia, Brain, 105, 461, 10.1093/brain/105.3.461 Shiang, 1993, Mutations in the a1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia, Nat Genet, 5, 351, 10.1038/ng1293-351 Shimura, 2000, Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase, Nat Genet, 25, 302, 10.1038/77060 Shimura, 2001, Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease, Science, 293, 263, 10.1126/science.1060627 Shy, 1960, A neurologic syndrome associated with orthostatic hypotension, Arch Neurol, 2, 511, 10.1001/archneur.1960.03840110025004 Sider, 1979, Galen on tremor, palpitation, spasm, and rigor: Galeni De tremore, palpitatione, convulsione, et rigore, Trans Stud Coll Physicians Phila, 1, 183 Siderowf, 1998, Posey and Spiller and progressive supranuclear palsy: an incorrect attribution, Mov Disord, 13, 170, 10.1002/mds.870130133 Siegfried, 1994, Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of extrapyramidal and cerebellar disorders. Personal experience since 1985, Stereotact Funct Neurosurg, 62, 71, 10.1159/000098599 Siegfried, 1994, Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms, Neurosurgery, 35, 1126, 10.1227/00006123-199412000-00016 Siemerling, 1922, Pseudosklerose (Westphal-Strumpell) mit Cornealring (Kayser-Fleischer) unter doppelseitiger Scheinkatarakt, die nur bei Seitlicherbeleuchtung sichtbar ist und die, der nach Verletzung durch kupfersplitterentstehenden Katarakt ähnlich ist, Klin Wochenschr, 1, 1087, 10.1007/BF01771550 Simpson, 2008, Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 70, 1699, 10.1212/01.wnl.0000311389.26145.95 Singer, 1982, Dopaminergic dysfunction in Tourette syndrome, Ann Neurol, 12, 361, 10.1002/ana.410120408 Sinkler, 1895, Choreiform affections, 227 Slavin, 2004, Treatment of hemiballismus with stereotacticc pallidotomy. Case report and review of the literature, Neurosurg Focus, 17, E7, 10.3171/foc.2004.17.1.7 Smith, 1988, Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity, Brain Res, 453, 353, 10.1016/0006-8993(88)90177-1 Snell, 1993, Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease, Nat Genet, 4, 393, 10.1038/ng0893-393 Sokol, 1985, Orthotopic liver transplantation for acute fulminant Wilson disease, J Pediatr, 107, 549, 10.1016/S0022-3476(85)80016-0 Solly, 1864, Clinical lectures on scriveners' palsy, or the paralysis of writers: Lecture I, Lancet, ii, 709 Solly, 1865, Clinical lectures on scriveners' palsy, or the paralysis of writers: Lecture II, Lancet, i, 84, 10.1016/S0140-6736(02)69633-3 Solly, 1865, Clinical lectures on scriveners' palsy, or the paralysis of writers: Lecture III, Lancet, i, 113, 10.1016/S0140-6736(02)52480-6 1992, Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update, JAMA, 268, 2069, 10.1001/jama.1992.03490150121036 Speelman, 1998, Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective, Mov Disord, 13, 582, 10.1002/mds.870130336 Spiegel, 1947, Stereotaxic apparatus for operations on the human brain, Science, 106, 349, 10.1126/science.106.2754.349 Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 Spillantini, 1998, Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies, Neurosci Lett, 251, 205, 10.1016/S0304-3940(98)00504-7 Spiller, 1905, The importance in clinical diagnosis of paralysis of associative movement of the eyeballs (Blick-Lahmung) especially of upward and downward associated movements, J Nerv Ment Dis, 32, 417, 10.1097/00005053-190507000-00001 Squitieri, 2003, Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course, Brain, 126, 946, 10.1093/brain/awg077 Steck, 1954, Le syndrome extrapyramidal et diencephalique au cours des traitments au largactil et au serpasil, Ann Med Psychol (Paris), 112, 737 Steele, 1972, Progressive supranuclear palsy, Brain, 95, 693 Steele, 1994, Historical notes, J Neural Transm Suppl, 42, 3, 10.1007/978-3-7091-6641-3_1 Steele, 1964, Progressive supranuclear palsy, Arch Neurol, 10, 333, 10.1001/archneur.1964.00460160003001 Stine, 1993, Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15, Hum Molec Genet, 2, 1547, 10.1093/hmg/2.10.1547 Stollerman, 1997, Changing streptococci and prospects for the global eradication of rheumatic fever, Perspect Biol Med, 40, 165, 10.1353/pbm.1997.0044 Suarez, 1997, Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity, Ann Neurol, 42, 807, 10.1002/ana.410420519 Suhren, 1966, Hyperexplexia: a hereditary startle syndrome, J Neurol Sci, 3, 577, 10.1016/0022-510X(66)90047-5 Sweeney, 1997, What's in a name? Dr. Lewey and the Lewy body, Neurology, 49, 629, 10.1212/WNL.49.2.629 Sydenham, 1686 Sydenham, 1848, On St. Vitus's dance, 257 Tanzi, 1993, The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene, Nat Genet, 5, 344, 10.1038/ng1293-344 Taranta, 1956, The relationship of Sydenham's chorea to infection with Group A streptococci, Am J Med, 20, 170, 10.1016/0002-9343(56)90186-3 Telenius, 1993, Molecular analysis of juvenile Huntington's disease: the major influence on (CAG)n repeats length is the sex of affected parents, Hum Mol Genet, 2, 1535, 10.1093/hmg/2.10.1535 Telenius, 1994, Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm, Nat Genet, 6, 409, 10.1038/ng0494-409 Telenius, 1995, Somatic mosaicism in sperm is associated with intergenerational (CAG)n changes in Huntington disease, Hum Mol Genet, 4, 189, 10.1093/hmg/4.2.189 1993, Definitions and classification of tic disorders, Arch Neurol, 50, 1013, 10.1001/archneur.1993.00540100012008 Tiemann, 1899, 712 Todd, 1932, Antigenic streptococcal hemolysin, J Exp Med, 55, 267, 10.1084/jem.55.2.267 Tomonaga, 1977, Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy, Acta Neuropathol (Berl), 37, 1771, 10.1007/BF00692065 Trétiakoff, 1919 Trétiakoff, 1921, Contribution à l'étude de l'anatomie du locus niger, Rev Neurol (Paris), 28, 592 Trottier, 1994, Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset, J Med Genet, 31, 377, 10.1136/jmg.31.5.377 Truong, 1988, An early description of dystonia: translation of Schwalbe's thesis and information on his life, Adv Neurol, 50, 651 Tschermak von Seysenegg, 1900, Über künstliche Kreuzung bei Pisum sativum, Zeitschrift für das Landwirthschaftliche Versuchswesen in Oesterreich, 3, 465 Tsui, 1985, A pilot study on the use of botulinum toxin in spasmodic torticollis, Can J Neurol Sci, 12, 314, 10.1017/S031716710003540X Tsui, 1986, Double-blind study of botulinum toxin in spasmodic torticollis, Lancet, 2, 245, 10.1016/S0140-6736(86)92070-2 Tsui, 1987, Local treatment of spasmodic torticollis with botulinum toxin, Can J Neurol Sci, 14, 533, 10.1017/S0317167100038063 Tu, 1998, Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein, Ann Neurol, 44, 415, 10.1002/ana.410440324 Ueda, 1993, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc Natl Acad Sci USA, 90, 11282, 10.1073/pnas.90.23.11282 Uhrbrand, 1960, Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine, and electroconvulsive therapy, Psychopharmacologia, 1, 408, 10.1007/BF00441188 Unverricht, 1891 Uzman, 1956, The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease), Am J Med Sci, 231, 511, 10.1097/00000441-195605000-00004 Van Putten, 1975, The many faces of akathisia, Compr Psychiatry, 16, 43, 10.1016/0010-440X(75)90019-X Vesalius, 1542, De Humani Corporis Fabrica, J Oporini, Basel Vidailhet, 2005, Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia, N Engl J Med, 352, 459, 10.1056/NEJMoa042187 Vilensky, 2002, Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol]), Neurology, 59, 914, 10.1212/WNL.59.6.914 Vogt, 1929, Kupfer und Silber aufgespeichert in Auge, Leber, Milz und Nieren als Symptom der Pseudosklerose, Klin Monatsbl Augenheilkd, 83, 417 Vogt, 1920, Zur Lehre der Erkrankungen des striaren Systeme, Journal für Psychologie und Neurologie, 25, 627 von Economo, 1917, Encephalitis Lethargica, Wien Klin Wochenschr, 30, 581 von Economo, 1918 von Economo, 1929 von Economo, 1931 von Strümpel, 1898, Über die Westphal'sche Pseudosklerose und über diffuse Hirnsklerose insbesondere bei Kindern, Dtsch Z Nervenheilkd, 12, 115, 10.1007/BF02456569 Vonsattel, 1985, Neuropathological classification of Huntington's disease, J Neuropathol Exp Neurol, 44, 559, 10.1097/00005072-198511000-00003 Wakabayashi, 1998, Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy, Neurosci Lett, 249, 180, 10.1016/S0304-3940(98)00407-8 Walshe, 1920, On the symptom complexes of lethargic encephalitis with special reference to the involuntary muscular contractions, Brain, 43, 197, 10.1093/brain/43.3.197 Walshe, 1956, Penicillamine, a new oral therapy for Wilson's disease, Am J Med, 21, 487, 10.1016/0002-9343(56)90066-3 Walshe, 1960, The treatment of Wilson's disease with penicillamine, Lancet, 1, 188, 10.1016/S0140-6736(60)90109-4 Walshe, 1962, Wilson's disease: the presenting symptoms, Arch Dis Child, 37, 253, 10.1136/adc.37.193.253 Walshe, 1968, Toxic reactions to penicillamine in patients with Wilson's disease, Postgrad Med J (Suppl), 6 Walshe, 1982, Treatment of Wilson's disease with trientine (triethylene tetramine) dichloride, Lancet, 1, 643, 10.1016/S0140-6736(82)92201-2 Walshe, 2003, The story of penicillamine: a difficult birth, Mov Disord, 18, 853, 10.1002/mds.10458 Walshe, 2006, History of Wilson's disease: 1912 to 2000, Mov Disord, 21, 142, 10.1002/mds.20694 Wasmuth, 1988, A highly polymorphic locus very tightly linked to the Huntington's disease gene, Nature, 332, 734, 10.1038/332734a0 Waters, 1842, 312 West, 1861, On a peculiar form of infantile convulsions, Lancet, i, 724 Westphal, 1883, Über eine dem Bilde der cerebrospinalen grauen Degeneration ähnliche Erkrankung des centralen Nervensystems ohne anatomischen Befund, nebst einigen Bemerkungen über paradoxe Contraktion, Arch Psychiatr Nervenkr, 14, 87, 10.1007/BF02004266 Wexler, 1987, Homozygotes for Huntington's disease, Nature, 326, 194, 10.1038/326194a0 Whittier, 1947, Ballism and subthalamic nucleus (nucleus hypothalamicus; corpus Luysi). Review of the literature and study of thirty cases, Arch Neurol Psychiatry, 58, 672, 10.1001/archneurpsyc.1947.02300350022002 Whittier, 1949, Studies on the subthalamus of the rhesus monkey. I. Anatomy and fiber connections of the subthalamic nucleus of Luys, J Comp Neurol, 90, 281, 10.1002/cne.900900303 Whittier, 1949, Studies on the subthalamus of the rhesus monkey. II. Hyperkinesia and other physiologic effects of subthalamic lesions, with special reference to the subthalamic nucleus of Luys, J Comp Neurol, 90, 319, 10.1002/cne.900900304 Wichmann, 1998, Models of basal ganglia function and pathophysiology of movement disorders, Neurosurg Clin N Am, 9, 223, 10.1016/S1042-3680(18)30261-4 Willis, 1685, 413 Wilson, 1911 Wilson, 1912, Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, Brain, 34, 295, 10.1093/brain/34.4.295 Wilson, 1912, Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, Lancet, 1, 1115, 10.1016/S0140-6736(01)67414-2 Wilson, 1912, Dégénération lenticulaire progressive: maladie familiale associée à la cirrhose du foie, Rev Neurol (Paris), 23, 229 Wilson, 1914, Progressive Degeneration des Linsenkerns, 950 Wilson, 1925, Disorders of motility and muscle tone with special reference to the corpus striatum (Croonian Lectures), Lancet, 2, 215 Winkler, 1974, Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties, N Engl J Med, 290, 984, 10.1056/NEJM197405022901802 Winslow, 1986, Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics, Am J Psychiatry, 143, 706 Yahr, 1969, Treatment of parkinsonism with levodopa, Arch Neurol, 21, 343, 10.1001/archneur.1969.00480160015001 Yang, 2002, Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells, Hum Molec Genet, 11, 2905, 10.1093/hmg/11.23.2905 Yoon, 2003, Huntington disease expansion mutations in humans can occur before meiosis is completed, Proc Natl Acad Sci USA, 100, 8834, 10.1073/pnas.1331390100 Young, 1986, Asterixis: one type of negative myoclonus, Adv Neurol, 43, 137 Young, 1976, Unilateral asterixis produced by a discrete CNS lesion, Trans Am Neurol Assoc, 101, 306 Zabel, 1986, Mapping of the DNA locus D4S10 and the linked Huntington's disease gene to 4p16-p15, Cytogenet Cell Genet, 42, 187, 10.1159/000132276 Zeman, 1970, Pathology of the torsion dystonias (dystonia musculorum deformans), Neurology, 20, 79, 10.1212/WNL.20.11_Part_2.79 Zeman, 1967, Dystonia musculorum deformans: clinical, genetic and pathoanatomical studies, Psychiatr Neurol Neurochir, 70, 77 Zeman, 1959, Idiopathic dystonia musculorum deformans. I. The hereditary pattern, Am J Hum Genet, 11, 188 Zeman, 1960, Idiopathic dystonia musculorum deformans. II. The formes frustes, Neurology, 10, 1068, 10.1212/WNL.10.12.1068 Zesiewicz, 2005, Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, 64, 2008, 10.1212/01.WNL.0000163769.28552.CD Ziehen, 1911, Ein Fall von tonischer Torsionsneurose, Neurologisches Zentralblatt, 30, 109 Zoghbi, 2000, Glutamine repeats and neurodegeneration, Annu Rev Neurosci, 23, 217, 10.1146/annurev.neuro.23.1.217 Zuhlke, 1993, Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene, Hum Molec Genet, 2, 2063, 10.1093/hmg/2.12.2063